Elan Chief Executive Officer Kelly Martin

Elan Chief Executive Officer Kelly Martin

Elan Corp. via Bloomberg

Elan Chief Executive Officer Kelly Martin said the company hasn’t held talks with Royalty Pharma since it offered to buy Elan for about $6.5 billion, or $11 per American depositary receipt.